Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-094123

Chief Development Officer sold 100 shares at $73.51 ($7,351)

  • Chief Development Officer acquired 100 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-01 Exercise or conversion : show line 1 in the form 10b5-1 +100 $21.65 $2,165 5,587 D
2025-07-01 Sale : show line 2 in the form 10b5-1 −100 $73.51 $7,351 5,487 D
Open-market sales · 100 sh · avg $73.51 · $7,351

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-01 Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) −100 389,900 D
Loading xslF345X05/ownership.xml…